Literature DB >> 22886458

A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles.

Ebru Celik1, Onder Celik, Banu Kumbak, Ercan Yilmaz, Ilgin Turkcuoglu, Yavuz Simsek, Abdullah Karaer, Yagmur Minareci, Elif Ozerol, Kevser Tanbek.   

Abstract

OBJECTIVE: To determine whether concentrations of oxidative stress markers of follicular fluid and serum are different in GnRH agonist protocol from GnRH antagonist protocol. MATERIAL AND
METHOD: This was a cross-sectional study. Eighty-four women undergoing controlled ovarian stimulation with either GnRH agonist (n = 39) or GnRH antagonist protocols (n = 45) for IVF/ICSI treatment were assigned by a physician. Blood was obtained at the time of oocyte retrieval, and follicular fluid (FF) from the mature follicles of each ovary was centrifuged and frozen until analysis. Malondialdehyde (MDA), nitric oxide (NO), protein carbonyl (PC), hydroxyl proline (OH-P), sodium oxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), adenosine deaminase (ADA) and xanthine oxidase (XO) were assessed in the serum and follicular fluid of each participants.
RESULTS: The mean serum concentrations of GSH-Px, GSH and MDA were lower in the GnRH antagonist group compared to GnRH agonist group, but mean serum SOD was higher in the GnRH antagonist group. The mean follicular SOD, ADA and NO were higher in GnRH antagonist group than GnRH agonist group. The IVF/ICSI outcomes were similar in both groups. CONCLUSION(S): GnRH antagonist protocol is associated with increased oxidative stress. The relation of GnRH analogues with oxidative stress and its implication in follicular growth needs to be addressed in further studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886458      PMCID: PMC3510367          DOI: 10.1007/s10815-012-9843-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  49 in total

1.  Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial.

Authors:  M A Akman; H F Erden; S B Tosun; N Bayazit; E Aksoy; M Bahceci
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

2.  Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response.

Authors:  D Manau; J Balasch; W Jiménez; F Fábregues; S Civico; R Casamitjana; M Creus; J A Vanrell
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

3.  Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization.

Authors:  L Sabatini; C Wilson; A Lower; T Al-Shawaf; J G Grudzinskas
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

4.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Authors:  C Albano; R E Felberbaum; J Smitz; H Riethmüller-Winzen; J Engel; K Diedrich; P Devroey
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

5.  The role of gonadotropin-releasing hormone in murine preimplantation embryonic development.

Authors:  F Raga; E M Casañ; J Kruessel; Y Wen; F Bonilla-Musoles; M L Polan
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

Review 6.  Oxidative stress and the ovary.

Authors:  H R Behrman; P H Kodaman; S L Preston; S Gao
Journal:  J Soc Gynecol Investig       Date:  2001 Jan-Feb

7.  Glutathione (GSH) concentrations vary with the cell cycle in maturing hamster oocytes, zygotes, and pre-implantation stage embryos.

Authors:  Kurt A Zuelke; Susan C Jeffay; Robert M Zucker; Sally D Perreault
Journal:  Mol Reprod Dev       Date:  2003-01       Impact factor: 2.609

8.  Antioxidant defence in recurrent abortion.

Authors:  P Vural; C Akgül; A Yildirim; M Canbaz
Journal:  Clin Chim Acta       Date:  2000-05       Impact factor: 3.786

Review 9.  Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings.

Authors:  P Guérin; S El Mouatassim; Y Ménézo
Journal:  Hum Reprod Update       Date:  2001 Mar-Apr       Impact factor: 15.610

10.  Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).

Authors:  D de Jong; N S Macklon; M J Eijkemans; B M Mannaerts; H J Coelingh Bennink; B C Fauser
Journal:  Fertil Steril       Date:  2001-04       Impact factor: 7.329

View more
  2 in total

1.  Effects of multicycle gonadotropin-releasing hormone antagonist protocols on oxidative stress of follicular fluid and ovarian granulosa cells.

Authors:  Yucong Ma; Zhiming Zhao; Guimin Hao; Na Cui; Yanli Fan; Yucong Cao; Zhanwang Tan; Jingran Geng; Lijie Fan; Huilan Du; Bulang Gao
Journal:  Hum Cell       Date:  2021-05-08       Impact factor: 4.174

2.  Human follicular fluid shows diverse metabolic profiles at different follicle developmental stages.

Authors:  Jihong Yang; Ting Feng; Suying Li; Xinyue Zhang; Yun Qian
Journal:  Reprod Biol Endocrinol       Date:  2020-07-23       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.